Kapil Saxena, MD

Title(s)Assistant Clinical Professor, Medicine
SchoolSchool of Medicine
Address995 Potrero Avenue, #600
San Francisco CA 94110
ORCID ORCID Icon0000-0001-5393-7313 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Baylor College of Medicine, Houston, TXM.D.2016
    University of Texas at AustinB.A.2011
    University of California, San FranciscoResidency2019Internal Medicine
    MD Anderson Cancer Center, Houston, TXFellowship2022Hematology/Oncology

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses. Nat Cancer. 2024 Sep 19. DiNardo CD, Verma D, Baran N, Bhagat TD, Skwarska A, Lodi A, Saxena K, Cai T, Su X, Guerra VA, Poigaialwar G, Kuruvilla VM, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, Hackman GL, Chaudhry S, Collins M, Sweeney SR, Busquets J, Rathore AS, Deng Q, Green MR, Grant S, Demo S, Choudhary GS, Sahu S, Agarwal B, Spodek M, Thiruthuvanathan V, Will B, Steidl U, Tippett GD, Burger J, Borthakur G, Jabbour E, Pemmaraju N, Kadia T, Kornblau S, Daver NG, Naqvi K, Short NJ, Garcia-Manero G, Tiziani S, Verma A, Konopleva M. PMID: 39300320.
      View in: PubMed   Mentions:
    2. A Short-Lived Crisis. J Hosp Med. 2021 10; 16(10):623-627. Saxena K, Dhaliwal G, Rao MN, Babik JM. PMID: 34328846.
      View in: PubMed   Mentions:    Fields:    
    3. SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AML. Clin Lymphoma Myeloma Leuk. 2022 03; 22(3):133-139. Saxena K, DiNardo C, Daver N, Konopleva M. PMID: 34602371.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer. 2021 10 15; 127(20):3761-3771. Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, DiNardo CD, Borthakur G, Pierce SA, Jabbour E, Wang SA, Bueso-Ramos C, Loghavi S, Tang G, Cheung CM, Alexander L, Kornblau S, Andreeff M, Garcia-Manero G, Ravandi F, Konopleva MY, Daver N. PMID: 34171128.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    5. Impact of frontline treatment approach on outcomes of myeloid blast phase CML. J Hematol Oncol. 2021 06 15; 14(1):94. Saxena K, Jabbour E, Issa G, Sasaki K, Ravandi F, Maiti A, Daver N, Kadia T, DiNardo CD, Konopleva M, Cortes JE, Yilmaz M, Chien K, Pierce S, Kantarjian H, Short NJ. PMID: 34130720; PMCID: PMC8204504.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    6. New Treatment Options for Older Patients with Acute Myeloid Leukemia. Curr Treat Options Oncol. 2021 03 20; 22(5):39. Saxena K, Konopleva M. PMID: 33743079.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Harnessing Apoptosis in AML. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S61-S64. Saxena K, DiNardo C, Daver N, Konopleva M. PMID: 32862872.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism. Expert Opin Investig Drugs. 2020 Sep; 29(9):973-988. Saxena K, Konopleva M. PMID: 32746655.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    9. A 54-Year-Old Man With Pancytopenia. JAMA. 2019 Mar 05; 321(9):895-896. Saxena K, Vu K, Nye HE. PMID: 30742201.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections. Methods Mol Biol. 2019; 1576:229-247. Zou WY, Blutt SE, Crawford SE, Ettayebi K, Zeng XL, Saxena K, Ramani S, Karandikar UC, Zachos NC, Estes MK. PMID: 28361480; PMCID: PMC5752619.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    11. A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U S A. 2017 01 24; 114(4):E570-E579. Saxena K, Simon LM, Zeng XL, Blutt SE, Crawford SE, Sastri NP, Karandikar UC, Ajami NJ, Zachos NC, Kovbasnjuk O, Donowitz M, Conner ME, Shaw CA, Estes MK. PMID: 28069942; PMCID: PMC5278484.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    12. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol. 2016 01 01; 90(1):43-56. Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, Graham DY, Qureshi W, Sherman V, Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Donowitz M, Estes MK. PMID: 26446608; PMCID: PMC4702582.
      View in: PubMed   Mentions: 214     Fields:    Translation:HumansCells
    13. Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency. J Allergy Clin Immunol. 2014 Dec; 134(6):1451-1453.e1. Kamili QUA, Seeborg FO, Saxena K, Nicholas SK, Banerjee PP, Angelo LS, Mace EM, Forbes LR, Martinez C, Wright TS, Orange JS, Hanson IC. PMID: 25159470; PMCID: PMC5182041.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    Kapil's Networks
    Concepts (67)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (4)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.